Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,891 | 268 | 93.5% |
| Education | $341.97 | 22 | 6.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $646.61 | 43 | $0 (2024) |
| Astellas Pharma US Inc | $436.70 | 25 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $357.51 | 18 | $0 (2023) |
| ABBVIE INC. | $357.36 | 23 | $0 (2023) |
| AMAG Pharmaceuticals, Inc. | $328.62 | 21 | $0 (2020) |
| MAYNE PHARMA COMMERCIAL LLC | $272.64 | 7 | $0 (2024) |
| Merck Sharp & Dohme LLC | $221.75 | 14 | $0 (2022) |
| Hologic, LLC | $208.02 | 12 | $0 (2022) |
| Exeltis, USA Inc. | $205.50 | 11 | $0 (2024) |
| Amgen Inc. | $205.03 | 13 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,142 | 57 | Astellas Pharma US Inc ($199.46) |
| 2023 | $1,030 | 44 | MAYNE PHARMA COMMERCIAL LLC ($227.82) |
| 2022 | $712.30 | 38 | MAYNE PHARMA INC. ($157.72) |
| 2021 | $184.58 | 10 | AbbVie Inc. ($35.52) |
| 2020 | $140.40 | 9 | PFIZER INC. ($31.44) |
| 2019 | $757.30 | 52 | PFIZER INC. ($146.20) |
| 2018 | $662.21 | 41 | AMAG Pharmaceuticals, Inc. ($192.05) |
| 2017 | $603.51 | 39 | PFIZER INC. ($151.66) |
All Payment Transactions
290 individual payment records from CMS Open Payments — Page 2 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/10/2024 | Biogen, Inc. | — | Food and Beverage | In-kind items and services | $23.86 | General |
| 06/04/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $21.69 | General |
| Category: Biological | ||||||
| 06/04/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $13.10 | General |
| Category: Oncology | ||||||
| 05/30/2024 | Hologic Sales and Service, LLC | THINPREP 2000 PROCESSOR (Device), APTIMA | Food and Beverage | In-kind items and services | $16.96 | General |
| Category: Diagnostics | ||||||
| 05/28/2024 | Exeltis, USA Inc. | SLYND (Drug) | Food and Beverage | In-kind items and services | $23.84 | General |
| Category: CONTRACEPTIVE | ||||||
| 05/23/2024 | PFIZER INC. | PREMARIN (Drug), MYFEMBREE, NURTEC ODT | Food and Beverage | In-kind items and services | $21.51 | General |
| Category: WOMENS HEALTH | ||||||
| 05/21/2024 | Agile Therapeutics, Inc. | Twirla (Drug) | Food and Beverage | In-kind items and services | $21.83 | General |
| Category: Birth Control Contraceptive Patch | ||||||
| 05/16/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $21.99 | General |
| Category: Biological | ||||||
| 05/14/2024 | MILLICENT US INC | FEMRING (Drug), INTRAROSA | Food and Beverage | In-kind items and services | $17.40 | General |
| Category: TREAT SYMPTOMS OF MENOPAUSE | ||||||
| 05/07/2024 | PFIZER INC. | ABRYSVO (Biological) | Food and Beverage | In-kind items and services | $26.12 | General |
| Category: VACCINES | ||||||
| 05/07/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $3.66 | General |
| Category: Biological | ||||||
| 04/23/2024 | Biogen, Inc. | — | Food and Beverage | In-kind items and services | $17.50 | General |
| 04/09/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $16.76 | General |
| Category: Bone Health | ||||||
| 04/02/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: Biological | ||||||
| 03/21/2024 | ASCEND THERAPEUTICS US, LLC | ESTROGEL (Drug) | Food and Beverage | In-kind items and services | $15.98 | General |
| Category: Women's Health | ||||||
| 03/20/2024 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $23.40 | General |
| Category: HORMONE THERAPY | ||||||
| 03/19/2024 | Organon Llc | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $23.69 | General |
| Category: ETONOGESTREL | ||||||
| 03/19/2024 | Evofem Biosciences, Inc. | — | Food and Beverage | In-kind items and services | $21.43 | General |
| 03/13/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $4.14 | General |
| Category: Biological | ||||||
| 03/06/2024 | CooperSurgical, Inc. | Paragard T 380A (Drug) | Food and Beverage | In-kind items and services | $17.72 | General |
| Category: Endocrinology | ||||||
| 03/04/2024 | Hologic Sales and Service, LLC | ACESSA PROVU SYSTEM (Device) | Food and Beverage | In-kind items and services | $32.15 | General |
| Category: Surgical | ||||||
| 02/27/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $44.82 | General |
| 02/22/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $21.69 | General |
| Category: Biological | ||||||
| 02/20/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $16.19 | General |
| Category: Oncology | ||||||
| 02/12/2024 | MILLICENT US INC | FEMRING (Drug), INTRAROSA | Food and Beverage | In-kind items and services | $20.24 | General |
| Category: TREAT SYMPTOMS OF MENOPAUSE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 606 | 628 | $70,145 | $25,605 |
| 2022 | 8 | 622 | 648 | $61,276 | $21,503 |
| 2021 | 8 | 747 | 784 | $46,644 | $27,201 |
| 2020 | 6 | 713 | 734 | $39,785 | $22,360 |
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 93 | 97 | $26,190 | $7,971 | 30.4% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2023 | 149 | 149 | $13,410 | $6,513 | 48.6% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2023 | 144 | 144 | $11,520 | $5,747 | 49.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 55 | 69 | $13,110 | $5,002 | 38.2% |
| 81003 | Automated urinalysis test | Office | 2023 | 165 | 169 | $5,915 | $371.80 | 6.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 78 | 80 | $20,340 | $6,656 | 32.7% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2022 | 91 | 91 | $7,931 | $4,055 | 51.1% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2022 | 94 | 94 | $7,276 | $3,803 | 52.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 53 | 67 | $11,920 | $3,522 | 29.6% |
| 82274 | Stool analysis for blood, by fecal hemoglobin determination by immunoassay | Office | 2022 | 154 | 154 | $5,390 | $2,423 | 45.0% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2022 | 17 | 18 | $3,600 | $694.05 | 19.3% |
| 81003 | Automated urinalysis test | Office | 2022 | 118 | 127 | $4,445 | $281.25 | 6.3% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2022 | 17 | 17 | $374.00 | $68.34 | 18.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 91 | 91 | $11,800 | $7,426 | 62.9% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2021 | 121 | 121 | $6,413 | $5,457 | 85.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 47 | 83 | $8,330 | $5,201 | 62.4% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2021 | 108 | 108 | $4,990 | $4,397 | 88.1% |
| 82274 | Stool analysis for blood, by fecal hemoglobin determination by immunoassay | Office | 2021 | 160 | 160 | $5,615 | $2,547 | 45.4% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 14 | 14 | $2,450 | $844.69 | 34.5% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2021 | 192 | 193 | $4,246 | $771.84 | 18.2% |
| 77080 | Bone density measurement of the core or central skeleton (e.g., hips, pelvis, spine) | Office | 2021 | 14 | 14 | $2,800 | $557.06 | 19.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 105 | 105 | $13,650 | $7,357 | 53.9% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2020 | 104 | 104 | $5,512 | $4,604 | 83.5% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2020 | 100 | 100 | $4,500 | $4,118 | 91.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 42 | 59 | $5,900 | $2,843 | 48.2% |
About Dr. Mary Poag, MD
Dr. Mary Poag, MD is a Gynecology healthcare provider based in Webster, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1275595969.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mary Poag, MD has received a total of $5,233 in payments from pharmaceutical and medical device companies, with $1,142 received in 2024. These payments were reported across 290 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($4,891).
As a Medicare-enrolled provider, Poag has provided services to 2,688 Medicare beneficiaries, totaling 2,794 services with total Medicare billing of $96,669. Data is available for 4 years (2020–2023), covering 27 distinct procedure/service records.
Practice Information
- Specialty Gynecology
- Location Webster, TX
- Active Since 04/06/2006
- Last Updated 10/28/2024
- Taxonomy Code 207VG0400X
- Entity Type Individual
- NPI Number 1275595969
Products in Payments
- PREMARIN (Drug) $402.43
- Veozah (Drug) $306.62
- INTRAROSA (Drug) $253.64
- Kyleena (Drug) $203.77
- MYFEMBREE (Drug) $193.53
- EVENITY (Biological) $174.57
- Mirena (Drug) $153.74
- Orilissa (Drug) $151.67
- NUVARING (Drug) $142.52
- NEXPLANON (Drug) $142.48
- LO LOESTRIN FE (Drug) $138.49
- PREMARIN ORALS (Drug) $122.11
- ZURZUVAE (Drug) $121.84
- MYRISK (Device) $115.60
- FEMRING (Drug) $105.62
- Tymlos (Biological) $95.34
- Myrbetriq (Drug) $94.79
- SLYND (Drug) $88.43
- MAKENA (Drug) $83.40
- ABRYSVO (Biological) $80.22
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.